vs

Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and MIMEDX GROUP, INC. (MDXG). Click either name above to swap in a different company.

COASTAL FINANCIAL CORP is the larger business by last-quarter revenue ($138.0M vs $118.1M, roughly 1.2× MIMEDX GROUP, INC.). On growth, MIMEDX GROUP, INC. posted the faster year-over-year revenue change (27.1% vs -5.8%). Over the past eight quarters, MIMEDX GROUP, INC.'s revenue compounded faster (18.1% CAGR vs -3.6%).

Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.

MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts for medical use.

CCB vs MDXG — Head-to-Head

Bigger by revenue
CCB
CCB
1.2× larger
CCB
$138.0M
$118.1M
MDXG
Growing faster (revenue YoY)
MDXG
MDXG
+32.9% gap
MDXG
27.1%
-5.8%
CCB
Faster 2-yr revenue CAGR
MDXG
MDXG
Annualised
MDXG
18.1%
-3.6%
CCB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCB
CCB
MDXG
MDXG
Revenue
$138.0M
$118.1M
Net Profit
$15.2M
Gross Margin
83.9%
Operating Margin
12.4%
17.8%
Net Margin
12.9%
Revenue YoY
-5.8%
27.1%
Net Profit YoY
104.2%
EPS (diluted)
$0.84
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCB
CCB
MDXG
MDXG
Q4 25
$138.0M
$118.1M
Q3 25
$144.7M
$113.7M
Q2 25
$119.4M
$98.6M
Q1 25
$139.5M
$88.2M
Q4 24
$146.5M
$92.9M
Q3 24
$151.1M
$84.1M
Q2 24
$135.3M
$87.2M
Q1 24
$148.4M
$84.7M
Net Profit
CCB
CCB
MDXG
MDXG
Q4 25
$15.2M
Q3 25
$13.6M
$16.7M
Q2 25
$11.0M
$9.6M
Q1 25
$9.7M
$7.0M
Q4 24
$7.4M
Q3 24
$13.5M
$8.1M
Q2 24
$11.6M
$17.6M
Q1 24
$6.8M
$9.3M
Gross Margin
CCB
CCB
MDXG
MDXG
Q4 25
83.9%
Q3 25
83.5%
Q2 25
81.1%
Q1 25
81.2%
Q4 24
81.8%
Q3 24
81.8%
Q2 24
83.0%
Q1 24
84.7%
Operating Margin
CCB
CCB
MDXG
MDXG
Q4 25
12.4%
17.8%
Q3 25
12.4%
19.5%
Q2 25
12.0%
12.5%
Q1 25
8.4%
9.4%
Q4 24
11.7%
11.9%
Q3 24
10.8%
13.3%
Q2 24
11.1%
26.9%
Q1 24
5.9%
15.6%
Net Margin
CCB
CCB
MDXG
MDXG
Q4 25
12.9%
Q3 25
9.4%
14.7%
Q2 25
9.2%
9.8%
Q1 25
7.0%
8.0%
Q4 24
8.0%
Q3 24
8.9%
9.6%
Q2 24
8.6%
20.2%
Q1 24
4.6%
10.9%
EPS (diluted)
CCB
CCB
MDXG
MDXG
Q4 25
$0.84
$0.10
Q3 25
$0.88
$0.11
Q2 25
$0.71
$0.06
Q1 25
$0.63
$0.05
Q4 24
$0.95
$0.05
Q3 24
$0.97
$0.05
Q2 24
$0.84
$0.12
Q1 24
$0.50
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCB
CCB
MDXG
MDXG
Cash + ST InvestmentsLiquidity on hand
$166.1M
Total DebtLower is stronger
$18.0M
Stockholders' EquityBook value
$491.0M
$256.5M
Total Assets
$4.7B
$342.7M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCB
CCB
MDXG
MDXG
Q4 25
$166.1M
Q3 25
$142.1M
Q2 25
$118.9M
Q1 25
$106.4M
Q4 24
$104.4M
Q3 24
$88.8M
Q2 24
$69.0M
Q1 24
$48.5M
Total Debt
CCB
CCB
MDXG
MDXG
Q4 25
$18.0M
Q3 25
Q2 25
Q1 25
Q4 24
$19.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CCB
CCB
MDXG
MDXG
Q4 25
$491.0M
$256.5M
Q3 25
$475.3M
$238.9M
Q2 25
$461.7M
$216.6M
Q1 25
$449.9M
$202.8M
Q4 24
$438.7M
$193.1M
Q3 24
$331.9M
$181.0M
Q2 24
$316.7M
$168.0M
Q1 24
$303.7M
$155.7M
Total Assets
CCB
CCB
MDXG
MDXG
Q4 25
$4.7B
$342.7M
Q3 25
$4.6B
$319.0M
Q2 25
$4.5B
$291.1M
Q1 25
$4.3B
$270.4M
Q4 24
$4.1B
$263.9M
Q3 24
$4.1B
$243.9M
Q2 24
$4.0B
$230.2M
Q1 24
$3.9B
$221.7M
Debt / Equity
CCB
CCB
MDXG
MDXG
Q4 25
0.07×
Q3 25
Q2 25
Q1 25
Q4 24
0.10×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCB
CCB
MDXG
MDXG
Operating Cash FlowLast quarter
$254.6M
$25.0M
Free Cash FlowOCF − Capex
$246.1M
FCF MarginFCF / Revenue
178.3%
Capex IntensityCapex / Revenue
6.1%
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters
$436.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCB
CCB
MDXG
MDXG
Q4 25
$254.6M
$25.0M
Q3 25
$59.0M
$29.3M
Q2 25
$66.0M
$14.4M
Q1 25
$71.7M
$5.3M
Q4 24
$259.8M
$18.8M
Q3 24
$62.6M
$19.6M
Q2 24
$72.1M
$21.8M
Q1 24
$56.8M
$6.0M
Free Cash Flow
CCB
CCB
MDXG
MDXG
Q4 25
$246.1M
Q3 25
$57.4M
Q2 25
$64.0M
Q1 25
$68.9M
Q4 24
$249.9M
Q3 24
$60.2M
Q2 24
$69.5M
Q1 24
$55.0M
FCF Margin
CCB
CCB
MDXG
MDXG
Q4 25
178.3%
Q3 25
39.7%
Q2 25
53.6%
Q1 25
49.4%
Q4 24
170.6%
Q3 24
39.8%
Q2 24
51.3%
Q1 24
37.1%
Capex Intensity
CCB
CCB
MDXG
MDXG
Q4 25
6.1%
Q3 25
1.2%
Q2 25
1.7%
Q1 25
2.0%
Q4 24
6.8%
Q3 24
1.6%
Q2 24
1.9%
Q1 24
1.2%
Cash Conversion
CCB
CCB
MDXG
MDXG
Q4 25
1.64×
Q3 25
4.34×
1.75×
Q2 25
5.99×
1.50×
Q1 25
7.37×
0.75×
Q4 24
2.53×
Q3 24
4.65×
2.42×
Q2 24
6.22×
1.24×
Q1 24
8.35×
0.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCB
CCB

Other$74.7M54%
Baa S Credit Enhancements$47.3M34%
Baa S Program Income$8.4M6%
Transaction Fees$4.9M4%
Servicing And Other Baa S Fees$1.6M1%
Baa S Fraud Enhancements$1.1M1%

MDXG
MDXG

Wound$78.7M67%
Surgical$39.4M33%

Related Comparisons